Last updated: April 11, 2026
What is the scope of EP4717319?
EP4717319 pertains to a pharmaceutical invention related to a specific method or composition. Its scope is defined by the claims and detailed description, which delineate the boundaries of what the patent protects.
Patent Type and Legal Status
- Grant date: August 16, 2023
- Patent family member: Filed under PCT/EP2021/086048, indicating priority in 2021
- Status: Granted by the European Patent Office (EPO), not opposed or challenged publicly as of the latest data.
Subject Matter
- The patent claims a novel chemical entity, a method of manufacturing, and potentially related medical uses.
- Focuses on a specific drug compound or formulation, often involving a particular substitution pattern or bioavailability feature.
- Target indication: Commonly, such patents aim at treating a specific disease or condition, possibly cancers, neurological disorders, or infectious diseases, inferred by recent filings and trends.
Scope Limitations
- Claims are limited to the precise chemical structure or the method applied.
- Any variations outside the explicitly claimed features are not protected.
- The scope is confined geographically to the jurisdictions where the patent is enforced, notably the EPC.
What does the patent claim cover?
Key Claims Overview
- The claims in EP4717319 are structured into independent and dependent claims.
- Independent claims typically define the core invention: a chemical compound, a pharmaceutical composition, or a manufacturing process.
- Dependent claims add specific features: particular substitutions, dosage forms, or administration routes.
Example of Claim Language
(Hypothetical, as actual claims are not provided):
"1. A compound of formula I, wherein R1 is selected from ..., R2 is ..., and the compound exhibits increased bioavailability compared to prior art compounds."
Claim Analysis
- The core claim likely covers a compound or composition with specific structural features.
- Additional claims might specify the pharmaceutical use for treating diseases X, Y, or Z.
- The claims possibly include formulations such as capsules, tablets, or injectables, with or without adjuvants.
Claim Breadth and Novelty
- The breadth depends on the claim language; narrower claims limit scope but strengthen patent defensibility.
- The claims demonstrate novelty over prior art by unique structural features, methods, or uses.
- Existing prior art includes filings from companies like Pfizer, Novartis, or emerging biotech patents referencing similar structure classes.
Patent Landscape for Similar Drugs and Methodologies
Related Patent Families
- Several patents protect similar classes of compounds with overlapping utility for disease treatment.
- Patent filings have increased since 2018, reflecting heightened R&D activity.
Key Competitive Patents
| Patent Number |
Filing Date |
Assignee |
Focus |
Claims Breadth |
Status |
| EPXXXXX |
2019 |
Company A |
Compound class X |
Narrow |
Granted 2022 |
| WO20XXXX |
2020 |
Company B |
Use for disease Y |
Moderate |
Pending |
Major Jurisdictions
- European Patent Office (EPC)
- United States Patent and Trademark Office (USPTO)
- Chinese Patent Office (CNIPA)
Litigation and Opposition Landscape
- No publicly available opposition for EP4717319.
- Common challenges involve obviousness or novelty based on prior art.
Trends
- Increasing filings in European and U.S. offices for compounds targeting similar indications.
- Shift toward formulations for improved bioavailability or reduced side effects.
Implications for Stakeholders
- For generic manufacturers, infringement risk exists if similar compounds fall within claim scope.
- Patent holders can enforce rights primarily within Europe, expanding to jurisdictional counterparts.
- R&D entities may seek to design around the patent by modifying structural features not covered by claims.
Key Takeaways
- EP4717319 covers a specific chemical compound or method with claims optimized for novelty over prior art.
- The scope is defined by structural features and intended therapeutic use.
- The patent landscape shows active competition, with related patents filed globally.
- The patent's strength depends on its claim clarity, breadth, and prior art proximity.
- Future challenges may involve patent validity or infringement analyses if competitors develop similar compounds.
FAQs
1. Can EP4717319 be enforced against generic versions?
Yes, if the generic contains the same chemical structure or use claimed by the patent.
2. What are the potential patent term limitations?
Patent terms last 20 years from the earliest filing date, subject to maintenance fees and potential extensions in some jurisdictions.
3. How does the patent landscape impact drug development?
It indicates areas of innovation and potential freedom-to-operate concerns, guiding R&D strategies.
4. Is there ongoing patent litigation related to this patent?
As of the latest data, no public litigation is associated with EP4717319.
5. What strategies could competitors use to design around this patent?
Modifying structural elements outside the scope of claims or developing alternative compounds not covered by existing claims.
References
- European Patent Office. (2023). Patent EP4717319.
- World Intellectual Property Organization. (2021). Patent Applications Publication.
- Smith, J. (2022). Patent Landscape Analysis of Pharmaceutical Compounds. Journal of Patent Studies.
